Top 20 global biopharma companies report 1.6 per cent per cent market cap growth to $3.67 tn in…
Four companies – Lilly (59.2 per cent), Novo Nordisk (51.5 per cent), Vertex Pharmaceuticals (41.4 per cent) and Regeneron…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
REVLIMID
Claims against Dr Reddy’s over Revlimid in US dismissed
On 22nd December, 2022 and 27th December, 2022, the plaintiffs voluntarily dismissed Dr Reddy’s Laboratories Limited and Dr…
Pfizer and BioNTech’s COVID-19 vaccine Comirnaty tops the list of best-selling drugs
Ends the nine-year reign of AbbVie’s Humira as the world’s best-selling pharma product
Sun Pharma announces settlement of patent litigation for generic Revlimid in the US
Pursuant to the terms of the settlement, Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture…
Natco Pharma gets USFDA approval for lenalidomide capsules
They are used to treat various types of cancers
Cipla settles patent litigation of Revlimid (lenalidomide) capsules with Celgene
Celgene has agreed to provide Cipla with a license to Celgene’s patents required to manufacture and sell certain volume-limited…